Qyuns Therapeutics Co., Ltd.

Qyuns Therapeutics Co., Ltd.verified

2509.HK

Price:

$20.46

Market Cap:

$4.13B

Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, focuses on the research and development of biologic therapies for autoimmune and allergic diseases in the People's Republic of China. The company's lead product candidates include QX002N, an interleukin (IL)-17A inhibitor in Phase III clinical trial for the treatment of ankylosing spondylitis and lupus nephritis; and QX005N, a monoclonal antibody (mAb) blocking IL-4Ra, which has completed Phase II clinical trial, to treat atopic dermatitis, prurigo nodularis, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria (CSU), asthma, and chronic obstructive pulmonary disease (COPD). It also develops QX001S, an IL-12/I...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

HKSE

Ticker

2509.HK

The Current Ratio as of December 2025 (TTM) for Qyuns Therapeutics Co., Ltd. (2509.HK) is 1.51

According to Qyuns Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.51. This represents a change of 2.44% compared to the average of 1.47 of the last 4 quarters.

Qyuns Therapeutics Co., Ltd. (2509.HK) Historical Current Ratio (quarterly & annually)

How has 2509.HK Current Ratio performed in the past?

The mean historical Current Ratio of Qyuns Therapeutics Co., Ltd. over the last ten years is 4.14. The current 1.51 Current Ratio has changed 3.54% with respect to the historical average. Over the past ten years (40 quarters), 2509.HK's Current Ratio was at its highest in in the December 2022 quarter at 5.20. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Quarterly (TTM)
Annual

Average

4.14

Median

3.75

Minimum

1.43

Maximum

7.61

Qyuns Therapeutics Co., Ltd. (2509.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Qyuns Therapeutics Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Current Ratio = 7.61

Minimum Annual Increase = -71.57%

Minimum Annual Current Ratio = 1.43

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.43-13.71%
20231.66-71.57%
20225.84-23.18%

Qyuns Therapeutics Co., Ltd. (2509.HK) Average Current Ratio

How has 2509.HK Current Ratio performed in the past?

The current Current Ratio of Qyuns Therapeutics Co., Ltd. (2509.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.98

5-year avg

4.14

10-year avg

4.14

Qyuns Therapeutics Co., Ltd. (2509.HK) Current Ratio vs. Peers

How is 2509.HK’s Current Ratio compared to its peers?

Qyuns Therapeutics Co., Ltd.’s Current Ratio is greater than AIM Vaccine Co., Ltd. (0.73), less than Viva Biotech Holdings (1.76), less than Jacobio Pharmaceuticals Group Co., Ltd. (7.53), less than Ocumension Therapeutics (5.29), less than Medtide Inc. (0), less than TYK Medicines, Inc (1.97), less than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (3.33), less than Antengene Corporation Limited (4.47), greater than Shanghai Kindly Medical Instruments Co., Ltd. (1.25), less than Modern Dental Group Limited (3.11),

Build a custom stock screener for Qyuns Therapeutics Co., Ltd. (2509.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qyuns Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Qyuns Therapeutics Co., Ltd. (2509.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Qyuns Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Qyuns Therapeutics Co., Ltd.'s Current Ratio?

How is the Current Ratio calculated for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the highest Current Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the 3-year average Current Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the 5-year average Current Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK)?

How does the current Current Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK) compare to its historical average?